Biotech
SYDNEY, AUSTRALIA: SYDNEY, AUSTRALIA -- (Marketwire) -- 02/03/13 -- Prima BioMed Ltd (ASX: PRR) (NASDAQ: PBMD) (ISIN: US74154B2034) ("Prima", "the Company") announces that two abstracts related to r ...
SOUTH SAN FRANCISCO, CA: SOUTH SAN FRANCISCO, CA -- (Marketwire) -- 01/31/13 -- Theravance, Inc. (NASDAQ: THRX) announced today that that Michael W. Aguiar, Theravance's Senior Vice President and Chief Financial Officer ...
DENVER, CO: DENVER, CO -- (Marketwire) -- 01/31/13 -- (OTCBB: OMBP), a biopharmaceutical company focused on the commercialization of alternative uses of alpha-1 antitrypsin (AAT) for the treatment of a variety o ...
LONDON, ONTARIO: LONDON, ONTARIO -- (Marketwire) -- 01/31/13 -- Critical Outcome Technologies Inc. (TSX VENTURE: COT) ("COTI" or the "Corporation") is pleased to announce that it has completed a ...
CHAPEL HILL, NC: CHAPEL HILL, NC -- (Marketwire) -- 01/31/13 -- (OTCQB: CWNM) is pleased to announce that it has achieved positive in-vitro testing results of the most widely prescribed Diabetes drug commonly known a ...
CAMBRIDGE, MA: CAMBRIDGE, MA -- (Marketwire) -- 01/30/13 -- Sarepta Therapeutics (NASDAQ: SRPT), a developer of innovative RNA-based therapeutics, today issued the following statement from Chris Garabedian, Preside ...
EDEN PRAIRIE, MN and SYDNEY, AUSTRALIA: EDEN PRAIRIE, MN and SYDNEY, AUSTRALIA -- (Marketwire) -- 01/29/13 -- Sunshine Heart, Inc. (NASDAQ: SSH) (ASX: SHC) () announced today that it intends to delist from the official list of the ASX duri ...
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwire) -- 01/29/13 -- Functional Technologies Corp. (TSX VENTURE: FEB) (the "Company") today reported operational and financial results for the first q ...
MONTREAL, CANADA: MONTREAL, CANADA -- (Marketwire) -- 01/29/13 -- Theratechnologies Inc. (TSX: TH)(NASDAQ: THER) today reported that the US Patent and Trademark Office (USPTO) has granted a patent (US Patent No. 8,36 ...
LONDON, ONTARIO: LONDON, ONTARIO -- (Marketwire) -- 01/29/13 -- Critical Outcome Technologies Inc. (COTI) (TSX VENTURE: COT) announced today that it has received acceptance from the TSX Venture Exchange (TSXV) to ex ...
SOUTH SAN FRANCISCO, CA and HONG KONG: SOUTH SAN FRANCISCO, CA and HONG KONG -- (Marketwire) -- 01/29/13 -- Portola Pharmaceuticals, Inc. and Lee's Pharmaceutical (HK) Ltd. (HKSE: 0950) today announced an agreement to jointly expand ...
OKLAHOMA CITY, OK: OKLAHOMA CITY, OK -- (Marketwire) -- 01/29/13 -- Cytovance® Biologics, Inc., a leading full-service contract manufacturer of mammalian and microbial biologics, announced today that it will expand it ...
SYDNEY, AUSTRALIA: SYDNEY, AUSTRALIA -- (Marketwire) -- 01/28/13 -- Prima BioMed Ltd (ASX: PRR) (NASDAQ: PBMD) (ISIN: US74154B2034) ("Prima", "the Company") has announced today that Matthew Lehman, ...
NEW YORK, NY: NEW YORK, NY -- (Marketwire) -- 01/28/13 -- Immunovative, Inc. (OTCQB: IMUN) ("IMUN" or "The Company") today announced that the Company is actively seeking potential acquisition t ...
WINNIPEG, MANITOBA: WINNIPEG, MANITOBA -- (Marketwire) -- 01/28/13 -- Miraculins Inc. (TSX VENTURE: MOM) ("Miraculins" or the "Company"), a medical diagnostic company focused on acquiring, developin ...
AURORA, ON: AURORA, ON -- (Marketwire) -- 01/25/13 -- Helix BioPharma Corp. (TSX: HBP) (FRANKFURT: HBP) (""), a biopharmaceutical company developing drug candidates for the prevention and treatment of ...
